Literature DB >> 25374212

Process evaluation of the first computer tailored program for smoking cessation among Romanian smokers.

Lucia Maria Lotrean1, Roxana Ailoaiei, Monica Popa, Hein de Vries.   

Abstract

The objective of this paper is to present the implementation and process evaluation of the first computer tailored program for smoking cessation among Romanian smokers. The program targeted adult smokers who declared the intention to quit smoking in the next six months. The intervention consisted of a letter tailored to several respondent characteristics: gender, cognitive variables (attitude, social influence, and self-efficacy), intention to quit smoking, goal and relapse prevention strategies (action and coping plans), and smoking behaviour. The first 80 participants entered into the program filled in a process evaluation questionnaire one month after the intervention. The results of our study confirmed that the participants had read and remembered the letter. Moreover, new for Romania, this approach was positively appreciated by the participant and the score received for the tailored letter was high. The opinions of the participants confirmed that the tailored letter provided information that was useful, trustworthy and relevant for the individual. At the same time, the participants appreciated the polite, easy to understand content of the letter. These data underlined the premises for continuing the program and for using the information and communication technologies for healthy lifestyle promotion among Romanian population.

Entities:  

Mesh:

Year:  2014        PMID: 25374212     DOI: 10.7314/apjcp.2014.15.20.8809

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  1 in total

1.  A recommender system to quit smoking with mobile motivational messages: study protocol for a randomized controlled trial.

Authors:  Santiago Hors-Fraile; Shwetambara Malwade; Dimitris Spachos; Luis Fernandez-Luque; Chien-Tien Su; Wei-Li Jeng; Shabbir Syed-Abdul; Panagiotis Bamidis; Yu-Chuan Jack Li
Journal:  Trials       Date:  2018-11-09       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.